Back to search

United Kingdom· GB-APID-3895211000001109

Dibenyline 10mg capsules

A phenoxybenzamine product containing phenoxybenzamine, registered in United Kingdom by Mercury Pharma Group Ltd. The same ATC class is registered in 4 of our 19 countries.

ATC C04AX02

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedDibenyline 10mg capsulesATCC04AX02REGISTER NO.GB-APID-3895211000001…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Phenoxybenzamine is registered in 4 of 19 countries.

Countries holding a registration under ATC C04AX02 (phenoxybenzamine), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 2 of them publish a price we can compare per daily dose

Phenoxybenzamine · ATC C04AX02

4 / 19 countries

  • Germany
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Phenoxybenzamine
Manufacturer
Mercury Pharma Group Ltd
Country
United Kingdom (GB)
ATC code
C04AX02
ATC class
Phenoxybenzamine
Defined daily dose
30 mg, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5021691100188

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

43 interactions on record for phenoxybenzamine.

Graded by severity as the source publishes them — 43 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Phenoxybenzamine · interactions on record

43 records

  • 43 moderate

Most severe, free to view

  • ThiethylperazinA04AB03moderate
  • DiphenhydraminA04AB05moderate
  • DronabinolA04AD10moderate
  • NabiloneA04AD11moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Phenoxybenzamine in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All phenoxybenzamine products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Germany · Dibenzyran 10

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7c08d6d0-a7cf-44fa-bef2-12f8257d9cbb
GET /v1/drugs/7c08d6d0-a7cf-44fa-bef2-12f8257d9cbb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "3895211000001109",
  "desc": "Dibenyline 10mg capsules (Mercury Pharma Group Ltd)",
  "form": "Oral capsule",
  "vpid": "41987311000001107",
  "source": "dmd",
  "vtm_id": "777173002",
  "strength": "10 mg",
  "substance": "Phenoxybenzamine",
  "ingredient": "Phenoxybenzamine hydrochloride",
  "supplier_code": "151601000001102"
}

See everything about phenoxybenzamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.